Home › Alopecia Areata › Nebraska › Omaha
Alopecia Areata clinical trials in Omaha, NE
5 studies for Alopecia Areata are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
RecruitingPhase 3
- Skin Specialists /ID# 283358, Omaha
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
RecruitingPhase 3
- Skin Specialists /ID# 259237, Omaha
A Study of LAD603 in Adults With Alopecia Areata
RecruitingPhase 2
- Investigator Site 1, Omaha
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
RecruitingPhase 3
- Ear, Nose & Throat Consultants, LLC, Omaha
- Skin Specialists, PC dba Schlessinger MD, Omaha
- Complete Behavior Health (Dr. Brittany Marshall, Licensed Psychologist), Papillion · 9 mi away
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
RecruitingPhase 3
- Skin Specialists, Pc, Omaha
Alopecia Areata trials in other cities
- Indianapolis, IN7 studies
- San Antonio, TX6 studies
- Miami, FL6 studies
- New York City, NY4 studies
- Irvine, CA3 studies
- Troy, MI3 studies
- Columbus, OH3 studies
- Portland, OR3 studies
- Houston, TX3 studies
- Spokane, WA3 studies
- Los Angeles, CA3 studies
Other studies in Omaha
- Prostate Cancer27 studies
- Non-Small Cell Lung Cancer24 studies
- Breast Cancer22 studies
- Colorectal Cancer18 studies
- Cancer (all types)18 studies
- Multiple Myeloma16 studies
- Non-Hodgkin Lymphoma14 studies
- Ovarian Cancer14 studies
- Pancreatic Cancer14 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Heart Failure13 studies
- Metastatic Cancer13 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.